111 Inc
SWB:8110
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
111 Inc (8110) under the Base Case is 6.01 EUR per share.
Compared with the current market price of 2.44 EUR, the stock appears
Undervalued by 59% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What 111 Does
111 Inc is a China-based healthcare company that connects drug makers, pharmacies, doctors, and patients through an online platform. It sells prescription medicines, over-the-counter drugs, and other health products, and it also helps people find and buy care through digital channels. Its main customers are consumers, pharmacies, and healthcare partners that need a faster way to source medicines and serve patients.
- Headquarters
- China CN
- Employees
- 1 238
- IPO date
- Sep 12, 2018
Balance Sheet
Recent Events
111 insiders are selling more than usual
Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.
Past 12 months
Continue Research
Decided on 111? Get an email when 111 Inc reaches the price you’d buy at. Free with an account.
Other 111 listings
What is the Intrinsic Value of one 111 Inc stock?
The intrinsic value for
111 Inc (8110) under the Base Case is 6.01 EUR.
Is 111 Inc stock undervalued or overvalued?
Compared with the current market price of 2.44 EUR, the stock appears Undervalued by 59% .